Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

12 accc-cancer.org | March–April 2020 | OI tools Approved Drugs • On Jan. 9, 2020, the U.S. Food and Drug and Administration (FDA) approved Ayvakit™ (avapritinib) (Blueprint Medicines, blueprintmedicines.com) for the treatment of adults with unresect- able or metastatic gastrointestinal stromal tumor harboring a platelet- derived growth factor receptor alpha exon 18 …
Accelerated Approvals Reconsidered None Changes in Dosing/Administration None Changes in Labeled Indications Imfinzi® (durvalumab) – AstraZeneca’s PD-L1 inhibitor was newly approved for use, in combination with gemcitabine and cisplatin, as treatment for adult patients with locally advanced or metastatic biliary tract cancer (BTC). The expansion beyond lung cancer—where the IO agent …
Accelerated Approvals Reconsidered None Changes in Dosing/Administration None Changes in Labeled Indications Imfinzi® (durvalumab) – AstraZeneca’s PD-L1 inhibitor was newly approved for use, in combination with gemcitabine and cisplatin, as treatment for adult patients with locally advanced or metastatic biliary tract cancer (BTC). The expansion beyond lung cancer—where the IO agent …
Accelerated Approvals Reconsidered None Changes in Dosing/Administration None Changes in Labeled Indications Imfinzi® (durvalumab) – AstraZeneca’s PD-L1 inhibitor was newly approved for use, in combination with gemcitabine and cisplatin, as treatment for adult patients with locally advanced or metastatic biliary tract cancer (BTC). The expansion beyond lung cancer—where the IO agent …
FAN-Patient-Financial-Counselor
FAN-Patient-Financial-Counselor
ACCC Capitol Hill Day Issue Briefs—March 14, 2018 THE CANCER DRUG PARITY ACT OF 2017 (H.R. 1409) BACKGROUND: Traditionally, intravenous (IV) and injected treatments were the primary methods of chemotherapy delivery. Today, patient-administered chemotherapy has become more prevalent and is the standard of care for many types of cancer. But insurance coverage has not kept pace …
JF04-President
JA09-President
JF09-Editor
The following websites allow you to search for multiple myeloma clinical trials. In addition, individual cancer centers and hospitals that conduct clinical trials may maintain listings of those trials on their websites. National Cancer Institute The National Cancer Institute (NCI) maintains a list of 8,000 open trials. The list includes trials supported by NCI, pharmaceutical companies, academic …
CHANGING MEDICINE. CHANGING LIVES.® ASCO 2023 Review: Lymphoid Malignancies Eric Mou, MD Clinical Assistant Professor Division of Hematology, Oncology, and Blood & Marrow Transplant The University of Iowa Disclosures None Outline ▪ SWOG S1826: N-AVD versus BV-AVD in untreated advanced-stage classic Hodgkin lymphoma ▪ Alliance A041702: IVO versus IV in older patients …
Many of the terms associated with biomarkers or biomarker testing require an understanding of basic genetics. As such, the following terms may be helpful for members of the multidisciplinary team.
Stephen Quake, PhD, spoke to CANCER BUZZ about the application of liquid biopsies across multiple cancer stages and their potential to improve patient outcomes, minimize financial toxicity, and create health equity through greater testing access and lower cost.
2024 Corporate Membership Program 1 Corporate Member Levels: Premier Platinum Gold Annual Fee per State Society $20,000 Limited to three (3) companies per State Society first come, first served $14,000 $10,000 Year-Round Visibility Digital ad on state society website Resources page 728 x 90 and 300 x 250 pixels available • One (1) dedicated stand-alone e-blast to …
2024 Corporate Membership Program 1 Corporate Member Levels: Premier Platinum Gold Annual Fee per State Society $20,000 Limited to three (3) companies per State Society first come, first served $14,000 $10,000 Year-Round Visibility Digital ad on state society website Resources page 728 x 90 and 300 x 250 pixels available • One (1) dedicated stand-alone e-blast to …
2024 Corporate Membership Program 1 2024 WAHO Corporate Membership Program Corporate Member Levels: Premier Platinum Gold Annual Fee per State Society $24,000 Limited to three (3) companies per State Society first come, first served $16,000 $10,000 Year-Round Visibility Digital ad on state society website Resources page 728 x 90 and 300 x 250 pixels available • One …